Picture of Advanced Enzyme Technologies logo

ADVENZYMES — Advanced Enzyme Technologies Cashflow Statement

0.000.00%
in flag iconLast trade - 00:00
Basic MaterialsAdventurousSmall CapHigh Flyer

Annual cashflow statement for Advanced Enzyme Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

C2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,7111,4041,8781,8742,325
Depreciation
Non-Cash Items-18.819.1-62.3-95.4-362
Unusual Items
Other Non-Cash Items
Changes in Working Capital-819-369-755-719-797
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,2231,4041,4141,4251,568
Capital Expenditures-281-381-423-338-522
Purchase of Fixed Assets
Other Investing Cash Flow Items243-2,601-223-553-219
Acquisition of Business
Sale of Fixed Assets
Change in Net Investments
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-37.9-2,982-646-891-741
Financing Cash Flow Items-229-92.2-85.3-33.4-24.2
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-485-258-592-725-704
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash754-1,709173-195145